• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Dextromethorphan O-demethylation polymorphism in Jordanians.

作者信息

Irshaid Y M, al-Hadidi H F, Rawashdeh N M

机构信息

Department of Pharmacology, Faculty of Medicine, University of Science and Technology, Irbid, Jordan.

出版信息

Eur J Clin Pharmacol. 1993;45(3):271-3. doi: 10.1007/BF00315395.

DOI:10.1007/BF00315395
PMID:8276053
Abstract

The O-demethylation of dextromethorphan (DMT) to dextrorphan (DRP) was studied in 241 unrelated, healthy Jordanian volunteers (171 males, 70 females). Urine was collected for 8 h following a single oral dose of DMT bromhydrate 30 mg. A thin-layer chromatographic (TLC) technique was used to identify the metaboliser phenotype. The frequency of the poor metaboliser phenotype was found to be 2.9% (approximate 95% confidence interval 0.8-5.0%). Applying the Hardy-Weinberg Law, the frequency of the recessive autosomal gene controlling poor metabolism was 0.17 (95% confidence interval 0.108-0.232).

摘要

相似文献

1
Dextromethorphan O-demethylation polymorphism in Jordanians.
Eur J Clin Pharmacol. 1993;45(3):271-3. doi: 10.1007/BF00315395.
2
Dextromethorphan O-demethylation in a large number of French Caucasian families.
Pharmacogenetics. 1992 Jun;2(3):135-8. doi: 10.1097/00008571-199206000-00005.
3
Dextromethorphan O-demethylation and dextrorphan glucuronidation in a French population.
Int J Clin Pharmacol Ther Toxicol. 1993 Aug;31(8):392-8.
4
Dextromethorphan metabolism in Jordanians: dissociation of dextromethorphan O-demethylation from debrisoquine 4-hydroxylation.
Eur J Drug Metab Pharmacokinet. 1996 Oct-Dec;21(4):301-7. doi: 10.1007/BF03189731.
5
Enzyme polymorphism on the metabolic O-demethylation of dextromethorphan in a South American population.
Medicina (B Aires). 1996;56(4):378-82.
6
Prediction of phenotype for dextromethorphan O-demethylation by using polymerase chain reaction in healthy volunteers.利用聚合酶链反应预测健康志愿者中右美沙芬O-去甲基化的表型
Arzneimittelforschung. 1995 Jan;45(1):41-3.
7
Polymorphic dextromethorphan metabolism: co-segregation of oxidative O-demethylation with debrisoquin hydroxylation.多态性右美沙芬代谢:氧化O-去甲基化与异喹胍羟基化的共分离。
Clin Pharmacol Ther. 1985 Dec;38(6):618-24. doi: 10.1038/clpt.1985.235.
8
Pharmacogenetics of dextromethorphan O-demethylation in man.
Xenobiotica. 1986 May;16(5):421-33. doi: 10.3109/00498258609050249.
9
Low frequency of dextromethorphan O-demethylation deficiency in a Chinese population.
Clin Pharmacol Ther. 1996 Dec;60(6):696-8. doi: 10.1016/S0009-9236(96)90219-2.
10
Dextromethorphan O-demethylation polymorphism in the Uruguayan population.
Eur J Clin Pharmacol. 1997;52(5):417-8. doi: 10.1007/s002280050312.

引用本文的文献

1
Metabolic capacity of CYP2D6 within an Iranian population (Mazandaran Province).伊朗人群(马赞德兰省)中CYP2D6的代谢能力。
Caspian J Intern Med. 2011 Spring;2(2):213-7.
2
Dextromethorphan metabolic phenotyping in an Iranian population.伊朗人群中右美沙芬的代谢表型分析
Eur J Clin Pharmacol. 2005 Feb;60(12):849-54. doi: 10.1007/s00228-004-0859-4. Epub 2005 Jan 19.
3
Dextromethorphan metabolism in Jordanians: dissociation of dextromethorphan O-demethylation from debrisoquine 4-hydroxylation.

本文引用的文献

1
The polymorphic 4-hydroxylation of debrisoquine in a Saudi arab population.沙特阿拉伯人群中异喹胍的多态性4-羟化作用
Xenobiotica. 1980 Nov;10(11):819-25. doi: 10.3109/00498258009033812.
2
A study of the debrisoquine hydroxylation polymorphism in a Nigerian population.尼日利亚人群中异喹胍羟基化多态性的研究。
Xenobiotica. 1980 Nov;10(11):811-8. doi: 10.3109/00498258009033811.
3
A family and population study of the genetic polymorphism of debrisoquine oxidation in a white British population.对英国白人人群中异喹胍氧化遗传多态性的家系及群体研究。
Eur J Drug Metab Pharmacokinet. 1996 Oct-Dec;21(4):301-7. doi: 10.1007/BF03189731.
J Med Genet. 1980 Apr;17(2):102-5. doi: 10.1136/jmg.17.2.102.
4
Defective oxidation of drugs: pharmacokinetic and therapeutic implications.药物氧化缺陷:药代动力学及治疗学意义
Clin Pharmacokinet. 1982 Jan-Feb;7(1):1-22. doi: 10.2165/00003088-198207010-00001.
5
Influence of genetic polymorphism on the metabolism and disposition of encainide in man.基因多态性对恩卡尼在人体中的代谢和处置的影响。
J Pharmacol Exp Ther. 1984 Mar;228(3):605-11.
6
Defective metabolism of metoprolol in poor hydroxylators of debrisoquine.在异喹胍羟化能力差的个体中,美托洛尔代谢存在缺陷。
Br J Clin Pharmacol. 1982 Aug;14(2):301-3. doi: 10.1111/j.1365-2125.1982.tb01982.x.
7
Pharmacogenetics of dextromethorphan O-demethylation in man.
Xenobiotica. 1986 May;16(5):421-33. doi: 10.3109/00498258609050249.
8
Enzymatic basis of the debrisoquine/sparteine-type genetic polymorphism of drug oxidation. Characterization of bufuralol 1'-hydroxylation in liver microsomes of in vivo phenotyped carriers of the genetic deficiency.药物氧化的去甲丙咪嗪/鹰爪豆碱型遗传多态性的酶学基础。对遗传缺陷的体内表型携带者肝脏微粒体中布呋洛尔1'-羟化作用的表征。
Biochem Pharmacol. 1987 Dec 1;36(23):4145-52. doi: 10.1016/0006-2952(87)90573-9.
9
Drug hydroxylator phenotype in Hungary.
Eur J Clin Pharmacol. 1987;32(3):325. doi: 10.1007/BF00607584.
10
Polymorphism in drug metabolism--implications for drug toxicity.
Arch Toxicol Suppl. 1986;9:138-46. doi: 10.1007/978-3-642-71248-7_16.